Indian Navy Eye Care Pharmaceuticals Tender 2026 TIMOLOL MALEATE COMOD System ISO 9001 2024
Bid Publish Date
09-Feb-2026, 9:04 am
Bid End Date
26-Feb-2026, 10:00 am
Location
Progress
RAQuantity
1090
Category
TIMOLOL MALEATE 0.5 PERCENTAGE PRESERVATIVE FREE WITH COMOD SYSTEM
Bid Type
Two Packet Bid
Key Highlights
- • Vendor Code Creation required; PAN, GSTIN, Cancelled Cheque, EFT Mandate documents mandatory
- • Quantity flexibility up to 50% at contract placement and during currency
- • Ophthalmic drug formulations listed with specific concentrations and bottle/tube sizes
- • GMP alignment implied; explicit standards not specified in data
- • No liquidation or bankruptcy proceedings allowed; financial integrity undertaking required
- • 11+ ophthalmic actives included; packaging in 5 mL/3 mL bottles and 5 g tubes
- • Delivery terms depend on original delivery period with extensions possible
Categories
10
Tender Overview
The Indian Navy (Department Of Military Affairs) invites bids for a range of ophthalmic pharmaceutical formulations, including TIMOLOL MALEATE preservative-free with COMOD system, BETAXOLOL EYE DROPS, CIPROFLOXACIN HCL, CYCLOPENTOLATE HCL, FLUCONAZOLE, HOMATROPINE, BRIMONIDINE TARTRATE, METHYL CELLULOSE, PHENYLEPHRINE, PILOCARPINE NITRATE, TROPICAMIDE, and BIMATOPROST in specified bottle/pack configurations. The procurement comprises 12 items with 5 mL or 3 mL bottle formats commonly used for ocular therapy. Estimated value and EMD are not disclosed in the data, but the scope includes multiple drug products and packaging requirements. The tender emphasizes vendor code creation, financial integrity, and streamlined submission for defense procurement. A delivery-time option clause permits quantity adjustments up to 50% and potential extensions at contracted rates, with minimum 30 days added if applicable. This tender targets suppliers capable of GMP-compliant ophthalmic solutions and related documentation. The buyer’s terms require financial standing verification and specific submission documents. Location and exact start/end dates are not provided.
Technical Specifications & Requirements
- Product category: ophthalmic drugs (eye drops/solutions) including TIMOLOL MALEATE 0.5% preservative-free with COMOD system, BETAXOLOL 0.25-0.5% bottle, CIPROFLOXACIN HCL 0.3% tube, CYCLOPENTOLATE HCL 1% solution, FLUCONAZOLE 0.3% bottle, HOMATROPINE HYDROCHLORIDE 2% solution, BRIMONIDINE TARTRATE 0.2%, METHYL CELLULOSE 2% solution, PHENYLEPHRINE HCL 10%, PILOCARPINE NITRATE 2%, TROPICAMIDE 1%, BIMATOPROST 0.03% bottle.
- Packaging: 5 mL or 3 mL bottles; 5 g tubes where applicable.
- Standards/Compliance: IS/IS0 alignment not specified; no explicit standards listed; emphasis on GMP-compatible ophthalmic formulations.
- Delivery: 12 items total; quantities and unit values unspecified; option clause allows +/- 50% quantity variation.
- Documentation: Vendor code creation, PAN, GST, canceled cheque, EFT mandate.
- Eligibility: No liquidation or bankruptcy; financial integrity and vendor verification required.
- Misc: No explicit BOQ quantities; 12 items with N/A for individual item data.
Terms, Conditions & Eligibility
- EMD: Not specified in data; bidders must demonstrate financial standing and upload an undertaking against liquidation or bankruptcy.
- Documents: PAN, GSTIN, Cancelled Cheque, EFT Mandate certified by bank.
- Price/Delivery: Option to adjust quantity by up to 50% at contract placement and during currency; delivery period adjustments calculated from original quantity, with minimum 30 days.
- Compliance: Bidders must create Vendor Code; provide required documents for registration; no dates provided.
- Penalties: Not specified; contract terms imply adherence to delivery extensions and quantity changes.
- Warranty/AMC: Not specified in tender data.
- Language: Data available in English; pharmacological items listed with standard ophthalmic agents.
Key Specifications
-
TIMOLOL MALEATE 0.5% preservative-free with COMOD system
-
BETAXOLOL EYE DROPS 0.25-0.5%
-
CIPROFLOXACIN HCL 0.3% in 5 g tube
-
CYCLOPENTOLATE HCL 1% solution
-
FLUCONAZOLE 0.3%
-
HOMATROPINE HYDROCHLORIDE 2%
-
BRIMONIDINE TARTRATE 0.2%
-
METHYL CELLULOSE 2% solution
-
PHENYLEPHRINE HCL 10%
-
PILOCARPINE NITRATE 2%
-
TROPICAMIDE 1%
-
BIMATOPROST 0.03%
Terms & Conditions
-
Quantity may change by ±50% at contract placement and during currency
-
Provide vendor-code creation documents and anti-liquidation undertakings
-
Delivery timeline extends with a minimum 30-day rule for extensions
Important Clauses
Payment Terms
Not specified in data; bidders should anticipate standard government terms and vendor-code compliance.
Delivery Schedule
Delivery period commences from last date of original delivery order; extensions calculated as (increased quantity ÷ original quantity) × original period; minimum 30 days.
Penalties/Liquidated Damages
Not specified; implied adherence to delivery deadlines and extension terms.
Bidder Eligibility
-
No liquidation or bankruptcy proceedings; financial standing undertaken
-
PAN, GSTIN, canceled cheque, EFT mandate submitted
-
Vendor code creation documentation completed
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
TIMOLOL MALEATE 0.5 PERCENTAGE PRESERVATIVE FREE WITH COMOD SYSTEM , BETAXOLOL EYE DROPS 0.25 PERCENT 0.5 PERCENT BOTT OF 5 ML , CIPROFLOXACIN HCL 0.3 PERCENT TUBE OF 5 GM , CYCLOPENTOLATE HCL 1 PERCENT OPTH SOLN BOTT OF 5 ML , FLUCONAZOLE 0.3 PERCENT WV BOTT OF 5 ML , HOMATROPINE HYDROCHLORIDE, SOLN 2 PERCENT , BRIMONIDINE TARTRATE 0.2 PERCENT, EYE DROPS , METHYL CELLULLOSE 2 PERCENT SOLN BOTT OF 5 ML , PHENYLEPHRINE HCL 10 PER WITH CHLORBUTOL 0.5 PER EYE DROPS , PILOCARPINE NITRATE EYE SOLUTION 2 PER BOTT OF 5 ML , TROPICAMIDE 1 PER WITH 5 PER PHENYLEPHRINE EYE DROPS, BOTT OF 5 ML , BIMATOPROST 0.03 PERCENT BOTT OF 3 ML
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-8952199.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
12 Items Sign in to view GEM price trends Sign in for GEM prices
TIMOLOL MALEATE 0.5 PERCENTAGE PRESERVATIVE FREE WITH COMOD SYSTEM
TIMOLOL MALEATE 0.5 PERCENTAGE PRESERVATIVE FREE WITH COMOD SYSTEM
BETAXOLOL EYE DROPS 0.25 PERCENT 0.5 PERCENT BOTT OF 5 ML
BETAXOLOL EYE DROPS 0.25 PERCENT 0.5 PERCENT BOTT OF 5 ML
CIPROFLOXACIN HCL 0.3 PERCENT TUBE OF 5 GM
CIPROFLOXACIN HCL 0.3 PERCENT TUBE OF 5 GM
CYCLOPENTOLATE HCL 1 PERCENT OPTH SOLN BOTT OF 5 ML
CYCLOPENTOLATE HCL 1 PERCENT OPTH SOLN BOTT OF 5 ML
FLUCONAZOLE 0.3 PERCENT WV BOTT OF 5 ML
FLUCONAZOLE 0.3 PERCENT WV BOTT OF 5 ML
HOMATROPINE HYDROCHLORIDE, SOLN 2 PERCENT
HOMATROPINE HYDROCHLORIDE, SOLN 2 PERCENT
BRIMONIDINE TARTRATE 0.2 PERCENT, EYE DROPS
BRIMONIDINE TARTRATE 0.2 PERCENT, EYE DROPS
METHYL CELLULLOSE 2 PERCENT SOLN BOTT OF 5 ML
METHYL CELLULLOSE 2 PERCENT SOLN BOTT OF 5 ML
PHENYLEPHRINE HCL 10 PER WITH CHLORBUTOL 0.5 PER EYE DROPS
PHENYLEPHRINE HCL 10 PER WITH CHLORBUTOL 0.5 PER EYE DROPS
PILOCARPINE NITRATE EYE SOLUTION 2 PER BOTT OF 5 ML
PILOCARPINE NITRATE EYE SOLUTION 2 PER BOTT OF 5 ML
TROPICAMIDE 1 PER WITH 5 PER PHENYLEPHRINE EYE DROPS, BOTT OF 5 ML
TROPICAMIDE 1 PER WITH 5 PER PHENYLEPHRINE EYE DROPS, BOTT OF 5 ML
BIMATOPROST 0.03 PERCENT BOTT OF 3 ML
BIMATOPROST 0.03 PERCENT BOTT OF 3 ML
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | TIMOLOL MALEATE 0.5 PERCENTAGE PRESERVATIVE FREE WITH COMOD SYSTEM | TIMOLOL MALEATE 0.5 PERCENTAGE PRESERVATIVE FREE WITH COMOD SYSTEM | 180 | pieces | hodeye | 30 | |
| 2 | BETAXOLOL EYE DROPS 0.25 PERCENT 0.5 PERCENT BOTT OF 5 ML | BETAXOLOL EYE DROPS 0.25 PERCENT 0.5 PERCENT BOTT OF 5 ML | 10 | pieces | hodeye | 30 | |
| 3 | CIPROFLOXACIN HCL 0.3 PERCENT TUBE OF 5 GM | CIPROFLOXACIN HCL 0.3 PERCENT TUBE OF 5 GM | 400 | pieces | hodeye | 30 | |
| 4 | CYCLOPENTOLATE HCL 1 PERCENT OPTH SOLN BOTT OF 5 ML | CYCLOPENTOLATE HCL 1 PERCENT OPTH SOLN BOTT OF 5 ML | 20 | pieces | hodeye | 30 | |
| 5 | FLUCONAZOLE 0.3 PERCENT WV BOTT OF 5 ML | FLUCONAZOLE 0.3 PERCENT WV BOTT OF 5 ML | 30 | pieces | hodeye | 30 | |
| 6 | HOMATROPINE HYDROCHLORIDE, SOLN 2 PERCENT | HOMATROPINE HYDROCHLORIDE, SOLN 2 PERCENT | 50 | pieces | hodeye | 30 | |
| 7 | BRIMONIDINE TARTRATE 0.2 PERCENT, EYE DROPS | BRIMONIDINE TARTRATE 0.2 PERCENT, EYE DROPS | 120 | pieces | hodeye | 30 | |
| 8 | METHYL CELLULLOSE 2 PERCENT SOLN BOTT OF 5 ML | METHYL CELLULLOSE 2 PERCENT SOLN BOTT OF 5 ML | 50 | pieces | hodeye | 30 | |
| 9 | PHENYLEPHRINE HCL 10 PER WITH CHLORBUTOL 0.5 PER EYE DROPS | PHENYLEPHRINE HCL 10 PER WITH CHLORBUTOL 0.5 PER EYE DROPS | 60 | pieces | hodeye | 30 | |
| 10 | PILOCARPINE NITRATE EYE SOLUTION 2 PER BOTT OF 5 ML | PILOCARPINE NITRATE EYE SOLUTION 2 PER BOTT OF 5 ML | 10 | pieces | hodeye | 30 | |
| 11 | TROPICAMIDE 1 PER WITH 5 PER PHENYLEPHRINE EYE DROPS, BOTT OF 5 ML | TROPICAMIDE 1 PER WITH 5 PER PHENYLEPHRINE EYE DROPS, BOTT OF 5 ML | 100 | pieces | hodeye | 30 | |
| 12 | BIMATOPROST 0.03 PERCENT BOTT OF 3 ML | BIMATOPROST 0.03 PERCENT BOTT OF 3 ML | 60 | pieces | hodeye | 30 |
Required Documents
PAN Card copy
GSTIN copy
Cancelled Cheque copy
EFT Mandate certified by Bank
Undertaking of financial standing (no liquidation/bankruptcy)
Corrigendum Updates
1 Update Update
Extended Deadline
26-Feb-2026, 10:00 am
Opening Date
26-Feb-2026, 10:30 am
Reverse Auction Schedule
Start
06-Mar-2026, 1:00 pm
End
07-Mar-2026, 1:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 24-02-2026 08:32:44 | |
| 2 | ********** Under PMA | - | 18-02-2026 10:23:29 |
Frequently Asked Questions
Key insights about KARNATAKA tender market
How to bid for Indian Navy ophthalmic drugs tender in 2026?
This bid requires non-liquidation proof, PAN, GSTIN, cancelled cheque, and EFT mandate. Prepare vendor-code registration documents and ensure GMP-aligned ophthalmic formulations, including TIMOLOL MALEATE 0.5% and BIMATOPROST 0.03%. Ensure you can handle ±50% quantity variations and comply with delivery-extension rules.
What documents are required for ophthalmic tender participation in India Navy?
Submit PAN Card, GSTIN, Cancelled Cheque, EFT Mandate certified by bank, and Undertaking confirming no liquidation or bankruptcy. Also provide vendor-code creation documents and any GMP/compliance certificates; ensure all documents reflect accurate organizational details and banking data.
What are the essential eye drop formulations listed for this procurement?
Key actives include TIMOLOL MALEATE 0.5% preservative-free with COMOD, BETAXOLOL 0.25-0.5%, CIPROFLOXACIN HCL 0.3%, CYCLOPENTOLATE HCL 1%, FLUCONAZOLE 0.3%, BRIMONIDINE TARTRATE 0.2%, BIMATOPROST 0.03%, plus PILOCARPINE NITRATE, PHENYLEPHRINE, TROPICAMIDE, and METHYL CELLULOSE 2% depending on packaging.
What delivery terms apply to quantity adjustments in this tender?
The buyer may increase or decrease order quantity up to 50% at contract placement and during currency. Delivery period extensions are computed as (increased quantity ÷ original quantity) × original period, with a minimum extension of 30 days; full compliance required for each variation.
Which standards or certifications are mandatory for ophthalmic products in this tender?
Explicit IS/ISO standards are not listed; emphasis is on GMP-aligned ophthalmic formulations and regulatory compliance for defense procurement; bidders should provide any available GMP certificates or pharmacopoeia references to strengthen bids.
What is the total number of items in the BOQ and item-level data?
There are 12 items in the BOQ, but individual item quantities and units are not disclosed in the available data; bidders should prepare for flexible packaging configurations matching 5 mL/3 mL bottles and 5 g tubes as specified.
What are the critical eligibility criteria for this Indian Navy tender?
Eligibility includes non-liquidation status, submission of PAN/GSTIN, cancelled cheque, EFT mandate, and vendor-code creation; bidders must demonstrate financial credibility and provide undertaking against bankruptcy; ensure compliance with delivery-quantity extension terms.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 4
GeM-Bidding-8952199.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS